Long non‐coding RNA CASC19 facilitates non‐small cell lung cancer cell proliferation and metastasis by targeting the miR‐301b‐3p/LDLR axis

Lijun Wang,Cunzhi Lin,Nina Sun,Qiang Wang,Xiaoqian Ding,Yong Sun
DOI: https://doi.org/10.1002/jgm.3254
2020-09-27
The Journal of Gene Medicine
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Non‐small cell lung cancer (NSCLC) is a lethal tumor bringing large number of cancer‐related deaths globally. Long noncoding RNAs (lncRNAs) may modulate tumor initiation and metastasis. Although dysregulation of lncRNA cancer susceptibility 19 (CASC19) is validated in NSCLC, further exploration of CASC19‐regulated mechanism in NSCLC is still needed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>CASC19 expression was examined in NSCLC cells by RT‐qPCR. The specific role of CASC19 in NSCLC was analyzed by CCK‐8, EdU, transwell and western blot assays. The interaction between miR‐301b‐3p and CASC19 or low density lipoprotein receptor (LDLR) was confirmed by luciferase reporter and RIP assays.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>CASC19 is markedly overexpressed in NSCLC. Its deficiency impairs cell proliferation as well as metastasis in NSCLC. Molecular mechanism experiments delineated that CASC19 negatively modulates the expression of miR‐301b‐3p and miR‐301b‐3p can bind with CASC19 in NSCLC. In addition, miR‐301b‐3p binds to LDLR to impair its expression in NSCLC. Finally, rescue experiments showed that miR‐301b‐3p inhibition or LDLR overexpression counteracted the CASC19 knockdown‐mediated function on cell proliferation and metastasis in NSCLC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>CASC19 facilitates NSCLC cell proliferation and metastasis by targeting the miR‐301b‐3p/LDLR axis, offering a possible strategy for lncRNA‐targeted treatment in NSCLC.</p></section>
genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?